Your institution may have access to this item. Find your institution then sign in to continue.
Title
Is Bioshield the Industry's Best Defense?
Abstract
Offers information on HE2100 and HE2200, the immune regulating hormone products of the company Hollis-Eden Pharmaceuticals suited for the Project Bioshield funding by the U.S. government. Purpose of the Project Bioshield federal government fund; Use of HE2100 in the prevention of infection after radiation exposure; Role of HE2200 as a possible treatment for traumatic shocks.